Nath Bio-Genes (India) Limited (NATHBIOGEN) — regulation 31 | 19 June 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Nath Bio-Genes (India) Limited filed its SEBI Regulation 31 disclosure for the year ended March 31, 2026, detailing promoter and public shareholding patterns. The filing includes updates on promoter group entities and their shareholding statuses as of April 7, 2026, submitted to BSE and NSE for compliance records.

📄 View Original Announcement (PDF)

About Nath Bio-Genes (India) Limited (NATHBIOGEN)

Fast Moving Consumer Goods · FMCG · Listed on NSE

Market Cap: ₹289.43 Cr P/E: 7.8 ROE: 6.0% ROCE: 7.9% Div Yield: 1.31%

View full NATHBIOGEN stock details →

📡 Get AI alerts when NATHBIOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NATHBIOGEN — Free

📊 More NATHBIOGEN filings

See all NATHBIOGEN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NATHBIOGEN files new disclosures

Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATHBIOGEN — Free

Free account · 2 AI queries/day